Clinical Trial Update: Evaluation of PCV21 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Prevnar 21 in PPSV23-experienced, immunocompromised elderly veterans; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Prevnar 21 (pneumococcal conjugate vaccine 21-valent)

Snippet

Sponsor: VA Sierra Nevada Health Care System | Conditions: Pneumococcal Vaccines, Immunosuppression | Phase 4 | Status: NOT_YET_RECRUITING